GlassScriptPhysician profile
Adam Scott Gropper
NPI 1790724110
$2,769.37
in general payments reported to CMS, 2019-2025
14 companies · $60.96 in 2025
The $60.96 reported for 2025 was less than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $726 · 2020: $1,459 · 2021: $282 · 2022: $87.04 · 2023: $75.15 · 2024: $80.20 · 2025: $60.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $216.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $216.31 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Medical Corporation | $1,458.74 | 2020 | |
| Boston Scientific Corporation | $348.68 | 2019-2022 | |
| Philips North America LLC | $190.61 | 2019-2022 | |
| Penumbra, INC. | $185.02 | 2019 | |
| Varian Medical Systems, INC. | $173.99 | 2019 | |
| Cook Medical LLC | $167.68 | 2021-2025 | Icast Covered Stent System, 6mmx22mmx120cm, Zilver Ptx, Zilver Vena |
| Bard Peripheral Vascular, INC. | $71.53 | 2019-2024 | Venovo |
| Guerbet LLC | $45.35 | 2021-2022 | |
| Becton, Dickinson and Company | $26.75 | 2023 | Venclose Maven Catheter |
| Inari Medical, INC. | $23.30 | 2021 | |
| Angiodynamics, INC. | $23.04 | 2023 | Venacure 1470 Pro |
| Biocompatibles, INC. | $20.45 | 2019 | |
| Medline Industries LP | $18.63 | 2022 | |
| Mindray Ds USA, INC. | $15.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Adam Gropper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.